18 April 2023
Unilabs appoints new CEO and Chair of the Board of Directors
Geneva, 18 April 2023: Unilabs, one of Europe’s most prominent diagnostics businesses that offers 360-degree integrated services across laboratory, imaging, and pathology; is reshaping its management team. Since being acquired by A.P. Moller Holding, Unilabs has been focusing on appointing the right team to unlock the growth potential.
The new CEO is not new to Unilabs, as he has held the position of Chair of the Board of Directors since July 2022. He brings a blend of strategic and operational insight from a career of more than three decades in commercial and operational roles, his latest role being that of Chief Supply Chain Officer at Unilever.
With Marc Engel stepping into the CEO role, Gilbert Achermann - currently member of the Unilabs Board of Directors - will be taking on the role of Chair of the Board of Directors. Gilbert Achermann brings considerable med-tech, healthcare and industrial experience, from a wide range of executive and board engagements including as the CEO and Chairman of the Straumann Group.
Gilbert Achermann, Chair: "I am very pleased that Marc Engel will take over the role as CEO of Unilabs. Diagnostics plays an absolutely essential role in healthcare, and Unilabs has a unique potential to further and transform the industry as a leading player. Marc brings great experience in setting a strategic vision, transforming organisations and motivating high-performing teams to achieve new goals. I am confident he will enable Unilabs to be best positioned to realise its future ambitions.”
Today Unilabs is present in 15 countries, working closely together with both private and public health care providers as well as with direct customers to help provide the right treatment decisions and the highest levels of patient care, therefore transforming lives.
Marc Engel, CEO, Unilabs: “I truly appreciate this opportunity, and look forward to working even more closely with our 13,000 passionate and talented employees. Unilabs has a strong foundation as a digitally driven diagnostics business and has differentiated itself as the only 360-degree integrated diagnostics provider in Europe offering services across laboratory, pathology and radiology. Yet, I believe we have only just begun and there is much more potential to be unlocked. I am looking forward to the exciting journey ahead and leading the Company into its next phase of ambitious growth.”
The appointment of a new CEO follows a series of organizational changes within Unilabs. In the role of CEO, Marc Engel succeeds Michiel Boehmer.